Shandong Provincial Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2022-03-18
- Employees
- -
- Market Cap
- -
- Website
- http://www.sph.com.cn
Neoadjuvant QL1706 Therapy for ESCC
Phase 2
Recruiting
- Conditions
- Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2025-04-03
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT06908382
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
The Effect of the Application of Head Mounted Magnifying Glasses on Postoperative PTH Changes in Thyroid Surgery: Stage II
Not Applicable
Active, not recruiting
- Conditions
- Thyroid Surgery
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT06838728
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
A Multicenter Randomized Controlled Phase II Trial of Iparomlimab and Tuvonralimab (QL1706) Combined with SOX Chemotherapy Versus Chemotherapy Alone in the Treatment of Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
- Interventions
- Drug: Neoadjuvant Therapy(QL1706+SOX Chemotherapy)Drug: Neoadjuvant Therapy(SOX Chemotherapy)Procedure: Radical surgery (D2)
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT06829797
Clinical Study of Low-dose Interval Radiotherapy Combined With Tirelizumab and SOX Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 2
Not yet recruiting
- Conditions
- Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
- Interventions
- Radiation: Neoadjuvant Therapy(5×3Gy radiotherapy)Drug: Neoadjuvant Therapy(tirelizumab, oxaliplatin, S-1)Procedure: Surgical treatmentDrug: Adjuvant therapy(SOX chemotherapy)
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT06766578
Iodine Status and Characteristics of Papillary Thyroid Cancer
Not yet recruiting
- Conditions
- Papillary Thyroid Carcinoma
- Interventions
- Dietary Supplement: Iodine excessDietary Supplement: Iodine suitable
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 600
- Registration Number
- NCT06626581
Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer
Recruiting
- Conditions
- Thyroid Cancer
- Interventions
- Dietary Supplement: Iodine excessDietary Supplement: Iodine suitable
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 1600
- Registration Number
- NCT06623500
- Locations
- 🇨🇳
Shandong Provincial Hospital, Jinan, Shandong, China
Iodine Supplementation in Graves' Hyperthyroidism
Not Applicable
Not yet recruiting
- Conditions
- HyperthyroidismGraves Disease
- Interventions
- Dietary Supplement: Iodine Restriction in Whole Course of Treatment with ATDsDietary Supplement: Iodine Supplementation in Whole Course of Treatment with ATDsDietary Supplement: Iodine Supplementation During Maintenance Treatment with ATDsDrug: anti-Thyroid Drugs
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 315
- Registration Number
- NCT06540469
Henagliflozin's Impact on Prediabetes Remission
Phase 4
Not yet recruiting
- Conditions
- Type 2 DiabetesGlucose Metabolism DisordersPrediabetic StatePreDiabetes
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 984
- Registration Number
- NCT06448130
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guanzhou, Guangdong, China
🇨🇳First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
🇨🇳Southern Medical University, Guangzhou, Guangdong, China
The Effect of the Number of Central Lymph Nodes on Changes in Parathyroid Function
Completed
- Conditions
- Thyroid Cancer
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT06432244
- Locations
- 🇨🇳
Shandong provincial hospital, Jinan, Shandong, China
The Effect of the Application of Head Mounted Magnifying Glasses on Postoperative PTH Changes in Thyroid Surgery
Completed
- Conditions
- Thyroid Cancer
- Interventions
- Device: head mounted magnifying glass assistance
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Shandong Provincial Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT06432257
- Locations
- 🇨🇳
Shandong provincial hospital, Jinan, Shandong, China
© Copyright 2025. All Rights Reserved by MedPath